SIMILAR PATTERNS OF AMINO ACIDS FOR 4IG3_A_T27A601

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1axd GLUTATHIONE
S-TRANSFERASE I


(Zea mays)
PF00043
(GST_C)
PF02798
(GST_N)
5 PRO A  55
LEU A   5
VAL A 206
VAL A   9
TYR A  28
None
1.48A 4ig3A-1axdA:
0.0
4ig3A-1axdA:
17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1doi 2FE-2S FERREDOXIN

(Haloarcula
marismortui)
PF00111
(Fer2)
5 PRO A  60
VAL A   3
TYR A 115
TYR A   5
PRO A 106
K  A 204 ( 4.6A)
None
None
None
None
1.24A 4ig3A-1doiA:
undetectable
4ig3A-1doiA:
14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kol FORMALDEHYDE
DEHYDROGENASE


(Pseudomonas
putida)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 249
VAL A 255
VAL A 212
TYR A 190
PRO A 253
None
1.09A 4ig3A-1kolA:
0.0
4ig3A-1kolA:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nmy SIMILAR TO
THYMIDYLATE KINASE
(DTMP KINASE)


(Homo sapiens)
PF02223
(Thymidylate_kin)
5 PRO A 127
LEU A 210
LYS A 118
VAL A 103
PRO A 120
None
1.26A 4ig3A-1nmyA:
undetectable
4ig3A-1nmyA:
17.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wic HYPOTHETICAL PROTEIN
RIKEN CDNA
6030424E15


(Mus musculus)
PF00635
(Motile_Sperm)
5 LEU A 131
VAL A  82
VAL A  55
TYR A  63
PHE A  29
None
1.44A 4ig3A-1wicA:
0.0
4ig3A-1wicA:
14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wpx CARBOXYPEPTIDASE Y
INHIBITOR


(Saccharomyces
cerevisiae)
PF01161
(PBP)
5 PRO B 532
LEU B 708
VAL B 524
TYR B 515
TYR B 668
None
1.35A 4ig3A-1wpxB:
0.0
4ig3A-1wpxB:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xea OXIDOREDUCTASE,
GFO/IDH/MOCA FAMILY


(Vibrio cholerae)
PF01408
(GFO_IDH_MocA)
5 LEU A  86
VAL A  67
VAL A  59
TYR A  56
PRO A  89
None
1.35A 4ig3A-1xeaA:
0.0
4ig3A-1xeaA:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1z9l VESICLE-ASSOCIATED
MEMBRANE
PROTEIN-ASSOCIATED
PROTEIN A


(Rattus
norvegicus)
PF00635
(Motile_Sperm)
5 LEU A 119
VAL A  71
VAL A  44
TYR A  52
PHE A  18
None
1.39A 4ig3A-1z9lA:
0.5
4ig3A-1z9lA:
12.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2erj CYTOKINE RECEPTOR
COMMON GAMMA CHAIN


(Homo sapiens)
PF00041
(fn3)
PF09240
(IL6Ra-bind)
5 LEU C 140
VAL C 165
TYR C 197
TYR C 167
PHE C 186
None
1.37A 4ig3A-2erjC:
0.0
4ig3A-2erjC:
17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f5u VIRION PROTEIN UL25

(Human
alphaherpesvirus
1)
PF01499
(Herpes_UL25)
5 PRO A 574
LEU A 406
VAL A 416
PRO A 145
TYR A 562
None
1.30A 4ig3A-2f5uA:
0.2
4ig3A-2f5uA:
20.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
8 LEU A 100
LYS A 103
VAL A 106
TYR A 181
TYR A 188
PRO A 225
PRO A 236
TYR A 318
PC0  A 999 ( 3.9A)
None
PC0  A 999 ( 4.8A)
PC0  A 999 (-3.9A)
PC0  A 999 (-4.1A)
None
PC0  A 999 ( 4.3A)
PC0  A 999 (-4.3A)
0.83A 4ig3A-2hnzA:
36.1
4ig3A-2hnzA:
98.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
8 LEU A 100
LYS A 103
VAL A 106
TYR A 188
PRO A 225
PHE A 227
PRO A 236
TYR A 318
PC0  A 999 ( 3.9A)
None
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.1A)
None
PC0  A 999 (-4.7A)
PC0  A 999 ( 4.3A)
PC0  A 999 (-4.3A)
0.91A 4ig3A-2hnzA:
36.1
4ig3A-2hnzA:
98.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
8 LEU A 100
VAL A 106
VAL A 179
TYR A 181
TYR A 188
PRO A 225
PRO A 236
TYR A 318
PC0  A 999 ( 3.9A)
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.4A)
PC0  A 999 (-3.9A)
PC0  A 999 (-4.1A)
None
PC0  A 999 ( 4.3A)
PC0  A 999 (-4.3A)
0.77A 4ig3A-2hnzA:
36.1
4ig3A-2hnzA:
98.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
8 LEU A 100
VAL A 106
VAL A 179
TYR A 188
PRO A 225
PHE A 227
PRO A 236
TYR A 318
PC0  A 999 ( 3.9A)
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.4A)
PC0  A 999 (-4.1A)
None
PC0  A 999 (-4.7A)
PC0  A 999 ( 4.3A)
PC0  A 999 (-4.3A)
0.86A 4ig3A-2hnzA:
36.1
4ig3A-2hnzA:
98.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
9 PRO A  95
LEU A 100
LYS A 103
VAL A 106
PRO A 225
PHE A 227
TRP A 229
PRO A 236
TYR A 318
PC0  A 999 ( 4.9A)
PC0  A 999 ( 3.9A)
None
PC0  A 999 ( 4.8A)
None
PC0  A 999 (-4.7A)
PC0  A 999 ( 4.2A)
PC0  A 999 ( 4.3A)
PC0  A 999 (-4.3A)
0.78A 4ig3A-2hnzA:
36.1
4ig3A-2hnzA:
98.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
9 PRO A  95
LEU A 100
LYS A 103
VAL A 106
TYR A 181
PRO A 225
TRP A 229
PRO A 236
TYR A 318
PC0  A 999 ( 4.9A)
PC0  A 999 ( 3.9A)
None
PC0  A 999 ( 4.8A)
PC0  A 999 (-3.9A)
None
PC0  A 999 ( 4.2A)
PC0  A 999 ( 4.3A)
PC0  A 999 (-4.3A)
0.87A 4ig3A-2hnzA:
36.1
4ig3A-2hnzA:
98.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
9 PRO A  95
LEU A 100
VAL A 106
VAL A 179
PRO A 225
PHE A 227
TRP A 229
PRO A 236
TYR A 318
PC0  A 999 ( 4.9A)
PC0  A 999 ( 3.9A)
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.4A)
None
PC0  A 999 (-4.7A)
PC0  A 999 ( 4.2A)
PC0  A 999 ( 4.3A)
PC0  A 999 (-4.3A)
0.72A 4ig3A-2hnzA:
36.1
4ig3A-2hnzA:
98.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hnz REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H


(Human
immunodeficiency
virus 1)
PF00075
(RNase_H)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
9 PRO A  95
LEU A 100
VAL A 106
VAL A 179
TYR A 181
PRO A 225
TRP A 229
PRO A 236
TYR A 318
PC0  A 999 ( 4.9A)
PC0  A 999 ( 3.9A)
PC0  A 999 ( 4.8A)
PC0  A 999 (-4.4A)
PC0  A 999 (-3.9A)
None
PC0  A 999 ( 4.2A)
PC0  A 999 ( 4.3A)
PC0  A 999 (-4.3A)
0.82A 4ig3A-2hnzA:
36.1
4ig3A-2hnzA:
98.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o4c ERYTHRONATE-4-PHOSPH
ATE DEHYDROGENASE


(Pseudomonas
aeruginosa)
PF00389
(2-Hacid_dh)
PF02826
(2-Hacid_dh_C)
PF11890
(DUF3410)
5 LEU A  42
TYR A 274
TYR A 271
PHE A  15
PRO A  10
None
1.18A 4ig3A-2o4cA:
undetectable
4ig3A-2o4cA:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p4b SIGMA-E FACTOR
REGULATORY PROTEIN
RSEB


(Escherichia
coli)
PF03888
(MucB_RseB)
PF17188
(MucB_RseB_C)
5 LEU A  31
VAL A 170
TYR A 156
PRO A 112
PRO A 167
None
1.23A 4ig3A-2p4bA:
1.4
4ig3A-2p4bA:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eqx FIC DOMAIN
CONTAINING
TRANSCRIPTIONAL
REGULATOR


(Shewanella
oneidensis)
PF02661
(Fic)
PF13784
(Fic_N)
5 LEU A 281
VAL A 339
VAL A 302
TYR A 288
PRO A 354
None
1.49A 4ig3A-3eqxA:
undetectable
4ig3A-3eqxA:
22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hhj MUTATOR MUTT PROTEIN

(Bartonella
henselae)
PF14815
(NUDIX_4)
5 PRO A  61
LEU A  75
VAL A  87
PHE A 113
PRO A  94
None
1.50A 4ig3A-3hhjA:
undetectable
4ig3A-3hhjA:
14.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l2e GLYCOCYAMINE KINASE
ALPHA CHAIN


(Namalycastis
sp. ST01)
PF00217
(ATP-gua_Ptrans)
PF02807
(ATP-gua_PtransN)
5 PRO A 120
LEU A 122
VAL A 248
VAL A 302
TYR A 290
None
1.18A 4ig3A-3l2eA:
3.2
4ig3A-3l2eA:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l7g XAA-PRO DIPEPTIDASE

(Alteromonas sp.)
PF00557
(Peptidase_M24)
5 PRO A  54
LEU A 340
LYS A 160
TYR A 153
TYR A 252
None
1.18A 4ig3A-3l7gA:
undetectable
4ig3A-3l7gA:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n3a PROTEIN NRDI

(Escherichia
coli)
PF07972
(Flavodoxin_NdrI)
5 LEU C  66
VAL C  46
VAL C  78
TYR C  42
PRO C  59
None
1.41A 4ig3A-3n3aC:
undetectable
4ig3A-3n3aC:
15.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w8s GLUTATHIONE
S-TRANSFERASE-3


(Necator
americanus)
PF02798
(GST_N)
PF14497
(GST_C_3)
5 PRO A  52
LEU A   6
TYR A   8
PRO A 202
TYR A  29
GSH  A 301 (-4.4A)
None
None
None
None
1.39A 4ig3A-3w8sA:
undetectable
4ig3A-3w8sA:
17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bp8 OLIGOPEPTIDASE B

(Trypanosoma
brucei)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
5 PRO A 638
LEU A 640
VAL A 590
VAL A 569
PRO A 656
None
1.46A 4ig3A-4bp8A:
0.6
4ig3A-4bp8A:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4by6 GENERAL NEGATIVE
REGULATOR OF
TRANSCRIPTION
SUBUNIT 1


(Saccharomyces
cerevisiae)
PF04054
(Not1)
5 VAL A1802
VAL A1798
TYR A1792
PHE A1788
TYR A1839
None
1.44A 4ig3A-4by6A:
undetectable
4ig3A-4by6A:
23.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jlw GLUTATHIONE-INDEPEND
ENT FORMALDEHYDE
DEHYDROGENASE


(Pseudomonas
aeruginosa)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 LEU A 250
VAL A 256
VAL A 213
TYR A 191
PRO A 254
None
1.12A 4ig3A-4jlwA:
undetectable
4ig3A-4jlwA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qfu GLYCOSIDE HYDROLASE
FAMILY 5


(Bacteroides
vulgatus)
PF12904
(Collagen_bind_2)
PF13204
(DUF4038)
5 LEU A 366
VAL A 473
TYR A 401
TYR A 472
PRO A 481
None
1.32A 4ig3A-4qfuA:
undetectable
4ig3A-4qfuA:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4w5k ASPARTATE
AMINOTRANSFERASE,
MITOCHONDRIAL


(Trypanosoma
brucei)
PF00155
(Aminotran_1_2)
5 LEU A 134
TYR A 137
TYR A 139
PRO A 174
PRO A 121
None
1.10A 4ig3A-4w5kA:
0.9
4ig3A-4w5kA:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wcj POLYSACCHARIDE
DEACETYLASE


(Ammonifex
degensii)
PF01522
(Polysacc_deac_1)
5 LEU A 242
VAL A  89
VAL A  40
TYR A  97
TYR A 219
None
1.33A 4ig3A-4wcjA:
undetectable
4ig3A-4wcjA:
18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wz0 E3 UBIQUITIN-PROTEIN
LIGASE LUBX


(Legionella
pneumophila)
PF04564
(U-box)
5 PRO A  38
LEU A  44
TYR A  56
PRO A  85
PRO A  87
None
1.42A 4ig3A-4wz0A:
undetectable
4ig3A-4wz0A:
12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wz3 E3 UBIQUITIN-PROTEIN
LIGASE LUBX


(Legionella
pneumophila)
PF04564
(U-box)
5 PRO B  38
LEU B  44
TYR B  56
PRO B  85
PRO B  87
None
1.41A 4ig3A-4wz3B:
undetectable
4ig3A-4wz3B:
18.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5c24 HIV-1 REVERSE
TRANSCRIPTASE, P51
SUBUNIT


(Human
immunodeficiency
virus 1)
PF00078
(RVT_1)
PF06815
(RVT_connect)
PF06817
(RVT_thumb)
5 LYS B 103
VAL B 106
VAL B 179
TYR B 181
TYR B 188
None
0.76A 4ig3A-5c24B:
19.4
4ig3A-5c24B:
96.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dhd CHITINASE

(Thermococcus
kodakarensis)
PF00553
(CBM_2)
5 VAL A 680
VAL A 655
TYR A 709
TYR A 679
TYR A 641
None
None
PE3  A 804 ( 3.9A)
PE3  A 804 (-3.8A)
None
1.22A 4ig3A-5dhdA:
undetectable
4ig3A-5dhdA:
10.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5evl BETA-LACTAMASE

(Chromobacterium
violaceum)
PF00144
(Beta-lactamase)
5 LEU A 110
VAL A 101
TYR A 136
PRO A 141
PRO A 145
None
1.31A 4ig3A-5evlA:
0.7
4ig3A-5evlA:
22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ey5 LBCA-B

(synthetic
construct)
PF00291
(PALP)
5 LEU B 313
VAL B 188
VAL B 228
PRO B 195
PRO B 308
None
None
PLP  B 501 ( 4.6A)
None
None
1.43A 4ig3A-5ey5B:
undetectable
4ig3A-5ey5B:
20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i32 AQUAPORIN TIP2-1

(Arabidopsis
thaliana)
PF00230
(MIP)
5 PRO A  84
LEU A 109
VAL A 206
PHE A 211
TRP A 218
None
1.34A 4ig3A-5i32A:
undetectable
4ig3A-5i32A:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xfm ALPHA-GLUCOSIDASE

(Bacteroides
thetaiotaomicron)
no annotation 5 VAL A 214
VAL A 239
TYR A 237
PHE A 153
TYR A  45
None
1.30A 4ig3A-5xfmA:
undetectable
4ig3A-5xfmA:
8.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xhw PUTATIVE
6-DEOXY-D-MANNOHEPTO
SE PATHWAY PROTEIN


(Yersinia
pseudotuberculosis)
no annotation 5 PRO A  25
LEU A  35
VAL A  75
PHE A  77
TYR A  36
None
1.49A 4ig3A-5xhwA:
0.8
4ig3A-5xhwA:
8.35